Addressing Barriers to Equitable Inclusion in Clinical Trials, With Dr. Miguel Regueiro, Dr. Neilanjan Nandi, and Ms. Tina Aswani-Omprakash
This activity is supported by educational grants from Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC.; Merck & Co., Inc.; and Takeda Pharmaceuticals U.S.A., Inc.

Already listened on another platform?
Overview
Provider Statement
This continuing education activity is provided by 
Support Statement
This activity is supported by educational grants from Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC.; Merck & Co., Inc.; and Takeda Pharmaceuticals U.S.A., Inc.
Activity Description
In this podcast, expert clinicians and a patient with IBD outline actionable strategies to enhance diversity in clinical trial recruitment and retention.
Target Audience
The intended audience for the activity is US-based physicians and advanced practice providers in gastroenterology involved in the management of patients with IBD.
Learning Objective
Upon successful completion of this activity, participants should be better able to outline actionable strategies to enhance diversity in clinical trial recruitment and retention.
Activity Chair
Miguel Regueiro, MD, AGAF, FACG, FACP
Chair, Digestive Disease and Surgery Institute
Professor of Medicine
Cleveland Clinic Lerner College of Medicine
Case Western Reserve University
Cleveland, OH
Faculty
Neilanjan Nandi, MD
Director of Clinical Operations and Co-Section Head
Penn IBD Program
Associate Professor of Medicine
Penn Presbyterian Medical Center
University of Pennsylvania
Philadelphia, PA
Patient Advocate
Tina Aswani-Omprakash, MPH
Planners/Reviewers
Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP
Linda A. Giarraputo, BS, PA-C
Accreditation
In support of improving patient care, Vindico Medical Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credit Designation
Vindico Medical Education designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Vindico Medical Education has been authorized by the American Academy of Physician Associates (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 0.50 AAPA Category 1 CME credits. Approval is valid until June 29, 2026. PAs should only claim credit commensurate with the extent of their participation.
Nurse practitioners can apply for AMA PRA Category 1 Credit(s)™ through the American Academy of Nurse Practitioners Certification Board (AANPCB). AANPCB will accept AMA PRA Category 1 Credit(s)™ from organizations accredited by ACCME.
This enduring material is approved for 1 year from the date of original release, June 30, 2025, to June 29, 2026.
How to Participate in This Activity and Obtain CE Credit
To participate in this activity, you must read the objective, answer the polling and pretest questions, listen to the podcasts, and complete the posttest and evaluation. Provide only one (1) correct answer for each question. A satisfactory score is defined as answering the posttest questions correctly. If a satisfactory score on the posttest is achieved, Vindico Medical Education will issue an AMA PRA Category 1 Credit(s)™ certificate or AAPA Category 1 CME certificate.
Disclosures
Vindico Medical Education adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a continuing education activity, including faculty, planners, reviewers, or others, are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.
Relationship information is accurate at the time of content development.
Activity Chair and Faculty report the following relevant financial relationship(s)
Neilanjan Nandi, MD
Advisor: AbbVie, Johnson & Johnson, Lilly, Sanofi
IBD Fellowship Grant Reviewer: Pfizer
Miguel Regueiro, MD, AGAF, FACG, FACP
Advisor: AbbVie, Amgen, BMS, Boehringer Ingelheim, Celgene, Genentech, Gilead, Janssen, Lilly, Organon, Pfizer, Prometheus, Salix, Takeda, UCB
Consultant: AbbVie, Amgen, BMS, Boehringer Ingelheim, Celgene, Genentech, Gilead, Janssen, Lilly, Organon, Pfizer, Prometheus, Salix, Takeda, UCB
Patient Advocate reports the following relevant financial relationship(s)
Tina Aswani-Omprakash, MPH
Advisor: Alimentiv, Ardelyx, Genentech/Roche, Johnson & Johnson, Merck, Parexel, Pfizer, Sanofi, Tillotts
Consultant: AbbVie, Alimentiv, Ardelyx, Convatec, Genentech/Roche, Johnson & Johnson, Parexel, Pfizer, Walgreens
Speaker Contracted by Ineligible Company: AbbVie, Alimentiv, Genentech/Roche, Johnson & Johnson, Lilly, Parexel, Pfizer, Takeda
Planners/Reviewers report the following relevant financial relationship(s)
Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP
No relevant financial relationships to disclose.
Linda A. Giarraputo, BS, PA-C
No relevant financial relationships to disclose.
Vindico Medical Education staff report the following relevant financial relationship(s)
No relevant financial relationships to disclose.
Signed disclosures are on file at Vindico Medical Education, Office of Medical Affairs and Compliance.
Unlabeled and Investigational Usage
The audience is advised that this continuing education activity may contain references to unlabeled uses of FDA-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non–FDA-approved or investigational use of products/devices.
ADA Compliance
In compliance with the Americans with Disabilities Act of 1990, we will make all reasonable efforts to accommodate persons with disabilities. A text-based transcript of this Podcast is available upon request. Requests should include the complete activity title and emailed to CME@VindicoCME.com. Requests will be honored within 3 to 5 business days.
Copyright Statement
Created and published by Vindico Medical Education, 6900 Grove Road, Building 100, Thorofare, NJ 08086-9447. Telephone: 856-994-9400; Fax: 856-384-6680. Printed in the USA. Copyright © 2025 Vindico Medical Education. All rights reserved. No part of this publication may be reproduced without written permission from the publisher. The material presented at or in any Vindico Medical Education continuing education activity does not necessarily reflect the views and opinions of Vindico Medical Education. Neither Vindico Medical Education nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the FDA. All readers and continuing education participants should verify all information before treating patients or utilizing any product.
CE Questions?
Contact us at cme@vindicoCME.com